Ropes & Gray represented the buyer group consortium of
TPG Growth and ShangPharma’s CEO, Michael Xin Hui, ShangPharma’s going private transaction, which closed March 27.ShangPharma is a leading, China-based contract research organization.The transaction ...
[Published Ropes & Gray - May 22 2013]